Atlas Trials

Study Examining The Effect Of Hepatic Impairment On Safety, Toleration And How The Body Processes An Experimental Drug

Clinical trial NCT00645021 · COMPLETED

Trial details

NCT number
NCT00645021
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
ObesityHepatic Insufficiency
Start date
2008-04-01
Primary completion
2008-10-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.